Serum magnesium levels in patients with hypertension

B. Ravi, S. Usha
{"title":"Serum magnesium levels in patients with hypertension","authors":"B. Ravi, S. Usha","doi":"10.15380/2277-5706.JCSR.14.004","DOIUrl":null,"url":null,"abstract":"Cardiovascular disease is one of the leading causes of death in adults and one of the main reasons for morbidity.1 Hypertension is one of the most important modifiable risk factors for cardiovascular disease.2 Factors implicated in the pathogenesis of hypertension, include changes in intracellular concentrations of calcium, sodium, potassium, and magnesium with an inverse correlation between serum magnesium and incidence of cardiovascular events.3 Experimental studies have shown a relationship between low serum and tissue magnesium levels and hypertension.4 Clinical and experimental studies have also shown a relationship between low dietary intake of magnesium with hypertension indicating a potential role of magnesium in the pathogenesis of hypertension. However, the mechanism is unclear.5,6 Effects of magnesium on smooth muscle cell growth and inflammation have been suggested to play a role.7 The role of serum/ dietary magnesium intake on cardiovascular disease, carot id intima-media thickness (CIMT), hypertension and cholesterol synthesis has been investigated. 8 Lower concentrations of magnesium are known to be associated with oxidat ive stress, proinflammatory state, endothelial dysfunction, platelet aggregation, insulin resistance, and hyperglycemia.7 Thus magnesium appears to play a vital function in cardiovascular stability and health, but an optimal dose and formulation has not been defined. Potentially promising avenues include the combination of magnesium with a statin to reduce cholesterol, C-reactive protein, CIMT, and its early use to reduce stroke morbidity and mortality.8 There are also reports on lack of association between low serum magnesium and risk of hypertension.9 Also, there are conflicting results on the effect of dietary intake of magnesium and risk of hypertension.10,11 Therefore, further studies are needed before advising this mineral supplementation as part of antihypertensive treatment.7 With this background the present study was taken up to assess serum magnesium levels in south Indian population with hypertension.","PeriodicalId":405143,"journal":{"name":"The Journal of Clinical and Scientific Research","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Clinical and Scientific Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15380/2277-5706.JCSR.14.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Cardiovascular disease is one of the leading causes of death in adults and one of the main reasons for morbidity.1 Hypertension is one of the most important modifiable risk factors for cardiovascular disease.2 Factors implicated in the pathogenesis of hypertension, include changes in intracellular concentrations of calcium, sodium, potassium, and magnesium with an inverse correlation between serum magnesium and incidence of cardiovascular events.3 Experimental studies have shown a relationship between low serum and tissue magnesium levels and hypertension.4 Clinical and experimental studies have also shown a relationship between low dietary intake of magnesium with hypertension indicating a potential role of magnesium in the pathogenesis of hypertension. However, the mechanism is unclear.5,6 Effects of magnesium on smooth muscle cell growth and inflammation have been suggested to play a role.7 The role of serum/ dietary magnesium intake on cardiovascular disease, carot id intima-media thickness (CIMT), hypertension and cholesterol synthesis has been investigated. 8 Lower concentrations of magnesium are known to be associated with oxidat ive stress, proinflammatory state, endothelial dysfunction, platelet aggregation, insulin resistance, and hyperglycemia.7 Thus magnesium appears to play a vital function in cardiovascular stability and health, but an optimal dose and formulation has not been defined. Potentially promising avenues include the combination of magnesium with a statin to reduce cholesterol, C-reactive protein, CIMT, and its early use to reduce stroke morbidity and mortality.8 There are also reports on lack of association between low serum magnesium and risk of hypertension.9 Also, there are conflicting results on the effect of dietary intake of magnesium and risk of hypertension.10,11 Therefore, further studies are needed before advising this mineral supplementation as part of antihypertensive treatment.7 With this background the present study was taken up to assess serum magnesium levels in south Indian population with hypertension.
高血压患者血清镁水平
心血管疾病是导致成人死亡的主要原因之一,也是导致成人发病的主要原因之一高血压是心血管疾病最重要的可改变危险因素之一与高血压发病有关的因素包括细胞内钙、钠、钾和镁浓度的变化,血清镁与心血管事件的发生率呈负相关实验研究表明,低血清和组织镁水平与高血压有关临床和实验研究也显示低膳食镁摄入量与高血压之间的关系,表明镁在高血压发病机制中的潜在作用。然而,其机制尚不清楚。镁对平滑肌细胞生长和炎症的影响已被认为起作用研究了血清/膳食镁摄入量对心血管疾病、胡萝卜内膜-中膜厚度(CIMT)、高血压和胆固醇合成的影响。镁的低浓度与氧化应激、促炎状态、内皮功能障碍、血小板聚集、胰岛素抵抗和高血糖有关因此,镁似乎在心血管稳定和健康中起着至关重要的作用,但最佳剂量和配方尚未确定。潜在的有前途的途径包括镁与他汀类药物联合使用以降低胆固醇、c反应蛋白、CIMT,以及早期使用以降低卒中发病率和死亡率也有报道称低血清镁与高血压风险之间缺乏联系此外,关于膳食镁摄入量与高血压风险的影响也有相互矛盾的结果。因此,在建议将这种矿物质补充剂作为抗高血压治疗的一部分之前,还需要进一步的研究在此背景下,本研究旨在评估印度南部高血压人群的血清镁水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信